Skip to search formSkip to main contentSkip to account menu

GS-7977

Known as: GS 7977, GS7977 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

sofosbuvir

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2014
Review
2014
Treatment of hepatitis C virus genotype 3‐infection
The treatment of hepatitis C virus (HCV) infection with pegylated interferon (PEG‐IFN) alfa and ribavirin (800 mg daily) (RBV) is… 
2013
2013
Patent battle lines drawn as sofosbuvir gains approval
hepatitis C virus (HCV) drug was approved by the US Food and Drug Administration on 6 December, the specialist antiviral company… 
2013
2013
1187 PK–PD MODELING IN A SUB-GROUP OF PATIENTS TREATED WITH GS-7977 AND RIBAVIRIN SHOWED A SIGNIFICANTLY SLOWER EARLY VIRAL KINETICS IN RELAPSERS
2012
2012
Deals center on self-reported patient data services
2012
2012
New agents for hepatitis C and the challenges in treating co‐infected patients
More recently, the improved understanding of the hepatitis C viral life cycle has led to the identification of numerous potential… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)